搜索





搜索





市场行情
/
股票
/
xers
/

Xeris Biopharma Holdings Inc

XERS

添加自选

8.080USD

-0.340-4.04%

收盘 07-31 16:00（美东）报价延迟15分钟

1.39B总市值

104.89市盈率 TTM

Xeris Biopharma Holdings Inc

8.080

-0.340-4.04%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

XERS 利润表

您可以在这里找到Xeris Biopharma Holdings Inc的年度或季度收入报告，以深入了解Xeris Biopharma Holdings Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

营业总收入

38.27%83.13M

42.78%85.81M

37.06%74.38M

48.84%71.54M

47.94%60.12M

35.39%60.10M

12.31%54.27M

26.46%48.06M

22.42%40.64M

33.93%44.39M

62.56%48.32M

50.19%38.01M

50.39%33.20M

54.67%33.14M

168.76%29.73M

184.15%25.31M

169.35%22.07M

198.79%21.43M

17.06%11.06M

339.37%8.91M

358.33%8.20M

291.70%7.17M

2918.53%9.45M

582.49%2.03M

620.97%1.79M

128.59%1.83M

-46.22%313.00K

-63.74%297.00K

-5.70%248.00K

71.52%801.00K

242.35%582.00K

44.96%819.00K

-25.71%263.00K

--467.00K

--170.00K

--565.00K

--354.00K

营业收入

38.27%83.13M

42.78%85.81M

37.06%74.38M

48.84%71.54M

47.94%60.12M

35.39%60.10M

12.31%54.27M

26.46%48.06M

22.42%40.64M

33.93%44.39M

62.56%48.32M

50.19%38.01M

50.39%33.20M

54.67%33.14M

168.76%29.73M

184.15%25.31M

169.35%22.07M

198.79%21.43M

17.06%11.06M

339.37%8.91M

358.33%8.20M

291.70%7.17M

2918.53%9.45M

582.49%2.03M

620.97%1.79M

128.59%1.83M

-46.22%313.00K

-63.74%297.00K

-5.70%248.00K

71.52%801.00K

242.35%582.00K

44.96%819.00K

-25.71%263.00K

--467.00K

--170.00K

--565.00K

--354.00K

主营业务成本

16.14%13.28M

12.05%13.66M

-15.93%13.71M

39.13%14.61M

31.74%11.44M

18.56%12.19M

49.41%16.30M

2.29%10.50M

8.12%8.68M

14.21%10.28M

36.90%10.91M

36.50%10.27M

-10.62%8.03M

65.51%9.00M

147.55%7.97M

122.29%7.52M

392.00%8.98M

59.64%5.44M

13.70%3.22M

160.43%3.38M

2.01%1.83M

117.01%3.41M

--2.83M

--1.30M

--1.79M

--1.57M

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--42.00K

--0.00

--4.00K

--0.00

营业费用

18.99%75.21M

18.17%69.03M

0.73%67.65M

19.21%67.06M

15.17%63.21M

7.72%58.42M

26.16%67.16M

4.20%56.25M

18.10%54.88M

12.25%54.23M

9.97%53.23M

22.08%53.99M

12.94%46.47M

-28.42%48.31M

46.16%48.41M

43.61%44.22M

67.03%41.15M

154.57%67.50M

42.80%33.12M

27.08%30.79M

-18.00%24.64M

-23.44%26.52M

-23.70%23.19M

-29.47%24.23M

16.96%30.04M

64.02%34.63M

95.78%30.39M

160.75%34.36M

114.17%25.68M

118.22%21.11M

100.53%15.53M

128.59%13.18M

139.72%11.99M

--9.68M

--7.74M

--5.76M

--5.00M

研发费用

13.29%8.78M

29.25%7.87M

27.09%7.48M

39.87%8.05M

-0.87%7.75M

-4.54%6.09M

16.96%5.89M

-5.39%5.76M

61.66%7.82M

28.80%6.38M

-16.70%5.03M

63.72%6.09M

-22.59%4.84M

-50.85%4.96M

6.71%6.04M

-30.93%3.72M

67.47%6.25M

97.30%10.08M

46.10%5.66M

1.78%5.38M

-43.85%3.73M

-58.86%5.11M

-75.02%3.88M

-72.64%5.29M

-49.53%6.65M

0.24%12.42M

42.69%15.52M

122.81%19.33M

51.14%13.17M

88.36%12.39M

89.96%10.88M

106.55%8.68M

137.90%8.71M

--6.58M

--5.72M

--4.20M

--3.66M

折旧摊销及损耗

-3.05%3.05M

-2.78%3.05M

-2.40%3.05M

-3.74%3.04M

-2.21%3.14M

-3.87%3.13M

-6.94%3.12M

-6.21%3.15M

1.04%3.21M

-6.97%3.26M

9.31%3.36M

9.83%3.36M

4.91%3.18M

289.66%3.50M

850.77%3.07M

856.88%3.06M

799.70%3.03M

101.57%899.00K

-15.67%323.00K

0.63%320.00K

5.31%337.00K

17.37%446.00K

12.98%383.00K

41.33%318.00K

138.81%320.00K

118.39%380.00K

6680.00%339.00K

188.46%225.00K

112.70%134.00K

222.22%174.00K

-90.38%5.00K

136.36%78.00K

65.79%63.00K

--54.00K

--52.00K

--33.00K

--38.00K

营业利润

356.18%7.92M

898.99%16.77M

152.21%6.73M

154.75%4.48M

78.31%-3.09M

117.06%1.68M

-162.43%-12.89M

48.76%-8.19M

-7.29%-14.24M

35.13%-9.84M

73.70%-4.91M

15.53%-15.98M

30.39%-13.28M

67.07%-15.17M

15.31%-18.68M

13.57%-18.92M

-16.02%-19.07M

-138.18%-46.07M

-60.49%-22.06M

1.43%-21.89M

41.81%-16.44M

41.03%-19.34M

54.31%-13.74M

34.81%-22.20M

-11.07%-28.25M

-61.47%-32.80M

-101.31%-30.08M

-175.63%-34.06M

-116.85%-25.44M

-120.59%-20.31M

-97.35%-14.94M

-137.68%-12.36M

-152.31%-11.73M

---9.21M

---7.57M

---5.20M

---4.65M

净非营业利息收入（费用）

利息收入

2.30%1.20M

60.55%1.46M

-3.26%1.16M

-26.57%948.00K

-38.90%1.18M

-17.80%910.00K

6.78%1.20M

5.56%1.29M

47.92%1.92M

-39.93%1.11M

137.50%1.12M

527.18%1.22M

1811.76%1.30M

2532.86%1.84M

615.15%472.00K

153.25%195.00K

-32.00%68.00K

-96.54%70.00K

-71.55%66.00K

-72.20%77.00K

-76.96%100.00K

215.94%2.02M

-64.69%232.00K

-67.22%277.00K

-35.32%434.00K

-21.66%640.00K

42.21%657.00K

255.04%845.00K

598.96%671.00K

934.18%817.00K

926.67%462.00K

--238.00K

--96.00K

--79.00K

--45.00K

--0.00

利息费用

-5.76%6.88M

-7.14%7.15M

-6.65%7.27M

-7.61%7.36M

3.88%7.30M

9.76%7.70M

13.71%7.79M

22.00%7.96M

13.13%7.03M

60.71%7.02M

71.65%6.85M

83.99%6.53M

179.87%6.22M

143.15%4.37M

121.86%3.99M

97.66%3.55M

24.01%2.22M

-60.88%1.80M

-22.77%1.80M

19.75%1.79M

19.48%1.79M

199.87%4.59M

-33.62%2.33M

41.15%1.50M

41.02%1.50M

45.12%1.53M

375.85%3.51M

88.97%1.06M

456.54%1.06M

105400.00%1.05M

--737.00K

56100.00%562.00K

--191.00K

--1.00K

--0.00

--1.00K

--0.00

特殊收入（费用）

----

-100.00%0.00

-99.95%1.00K

122.25%420.00K

-21.25%604.00K

-49.89%681.00K

-51.97%2.13M

-7092.59%-1.89M

118.03%767.00K

110.54%1.36M

247.88%4.43M

101.22%27.00K

-8.82%-4.25M

-4505.36%-12.89M

-5541.82%-2.99M

-1286.88%-2.22M

-400.00%-3.91M

-307.41%-280.00K

-63.82%55.00K

-266.67%-160.00K

-624.07%-782.00K

-75.54%135.00K

14.29%152.00K

-78.71%96.00K

64.71%-108.00K

773.17%552.00K

1050.00%133.00K

--451.00K

-856.25%-306.00K

---82.00K

---14.00K

--0.00

---32.00K

--0.00

其他非经营性收入（费用）

---5.68M

----

100.00%0.00

----

---1.00K

----

税前利润

124.23%2.23M

316.72%11.08M

103.26%621.00K

86.48%-1.93M

50.62%-9.22M

62.48%-5.11M

-52.17%-19.06M

30.52%-14.26M

-10.92%-18.67M

-2.70%-13.63M

43.50%-12.53M

22.65%-20.52M

50.67%-16.83M

73.88%-13.27M

14.76%-22.17M

3.60%-26.52M

-85.33%-34.12M

-132.37%-50.79M

-62.56%-26.01M

-13.66%-27.52M

36.91%-18.41M

34.83%-21.86M

51.27%-16.00M

29.59%-24.21M

-15.46%-29.18M

-64.26%-33.54M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

所得税

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-883.43%-3.32M

210.96%749.00K

--307.00K

30.18%-236.00K

0.29%-338.00K

-99.12%-675.00K

100.00%0.00

---338.00K

---339.00K

---408.00K

--0.00

100.00%0.00

--0.00

100.00%0.00

--0.00

---110.00K

----

---458.00K

--0.00

----

除税后利润

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

持续经营利润

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

归属于母公司的净利润

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

归属于普通股东的净利润

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

基本每股收益

121.66%0.01

294.75%0.07

103.59%0.00

88.05%-0.01

55.23%-0.06

64.65%-0.03

-19.64%-0.11

29.99%-0.10

-10.04%-0.14

-1.96%-0.10

45.02%-0.09

25.22%-0.14

50.84%-0.12

77.17%-0.10

58.94%-0.16

53.40%-0.19

16.95%-0.25

-2.11%-0.42

-12.81%-0.39

34.67%-0.41

66.22%-0.30

66.70%-0.41

71.55%-0.35

50.37%-0.63

17.04%-0.89

-25.76%-1.22

-71.30%-1.22

-103.71%-1.28

-77.82%-1.07

-110.15%-0.97

-86.55%-0.71

-136.79%-0.63

-156.12%-0.60

---0.46

---0.38

---0.27

---0.24

稀释每股收益

120.80%0.01

250.19%0.05

103.31%0.00

88.05%-0.01

55.23%-0.06

64.65%-0.03

-19.64%-0.11

29.99%-0.10

-10.04%-0.14

-1.96%-0.10

45.02%-0.09

25.22%-0.14

50.84%-0.12

77.17%-0.10

58.94%-0.16

53.40%-0.19

16.95%-0.25

-2.11%-0.42

-12.81%-0.39

34.67%-0.41

66.22%-0.30

66.70%-0.41

71.55%-0.35

50.37%-0.63

17.04%-0.89

-25.76%-1.22

-71.30%-1.22

-103.71%-1.28

-77.82%-1.07

-110.15%-0.97

-86.55%-0.71

-136.79%-0.63

-156.12%-0.60

---0.46

---0.38

---0.27

---0.24

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Xeris Biopharma Holdings Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 XERS 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Xeris Biopharma Holdings Inc 财年末的营收是多少？



Xeris Biopharma Holdings Inc 2025 财年营收为 291.85M，高于上一财年的203.07M。

Xeris Biopharma Holdings Inc 最近一个季度的营收是多少？



Xeris Biopharma Holdings Inc 最近一个季度的营收为 83.13M，同比增长 38.27%。

Xeris Biopharma Holdings Inc 全年的净利润是多少？



Xeris Biopharma Holdings Inc 2025 财年净利润为 554.00K。

Xeris Biopharma Holdings Inc 上一季度的净利润是多少？



Xeris Biopharma Holdings Inc 最近一个季度的净利润为 2.23M。

Xeris Biopharma Holdings Inc 年度营业利润是多少？



Xeris Biopharma Holdings Inc 2025 财年的营业利润为 24.90M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。